DARA BioSciences, Inc. (DARA) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 44 transactions totaling $221.1K, demonstrating a bullish sentiment with $221.1K in net insider flow. The most recent transaction on Dec 4, 2015 involved a transaction of 2,000 shares valued at $0.
No significant insider buying has been recorded for DARA in the recent period.
No significant insider selling has been recorded for DARA in the recent period.
Based on recent SEC filings, insider sentiment for DARA is bullish with an Insider Alignment Score of 100/100 and a net flow of $221.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at DARA BioSciences, Inc. (DARA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading DARA stock, having executed 44 transactions in the past 90 days. The most active insider is Richard A. Franco (Executive), who has made 12 transactions totaling $478.5K.
Get notified when executives and directors at DARA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 4, 2015 | James Heady Timothy | Executive | Disposition | 2,000 | $N/A | $0 | |
| Dec 4, 2015 | G. Clement Christopher | Executive | Disposition | 54,558 | $N/A | $0 | |
| Dec 4, 2015 | Drutz David | Executive | Disposition | 20,614 | $N/A | $0 | |
| Dec 4, 2015 | Lieberman Gail | Executive | Disposition | 41 | $N/A | $0 | |
| Dec 4, 2015 | D. Cochrane Haywood | Executive | Disposition | 5,614 | $N/A | $0 | |
| Jun 3, 2013 | G. Clement Christopher | Executive | Purchase | 14,000 | $0.71 | $9.9K | |
| May 30, 2013 | D. Cochrane Haywood | Executive | Purchase | 10,000 | $0.70 | $7.0K | |
| May 23, 2013 | James Heady Timothy | Executive | Purchase | 10,000 | $0.75 | $7.5K | |
| May 17, 2013 | Drutz David | Executive | Purchase | 25,000 | $0.70 | $17.5K | |
| Sep 17, 2012 | Drutz David | Executive | Purchase | 25,000 | $1.06 | $26.5K | |
| Sep 11, 2012 | D. Cochrane Haywood | Executive | Purchase | 2,800 | $0.82 | $2.3K | |
| Sep 10, 2012 | D. Cochrane Haywood | Executive | Purchase | 2,200 | $0.78 | $1.7K | |
| Jul 20, 2012 | D. Cochrane Haywood | Executive | Purchase | 9,000 | $0.73 | $6.6K | |
| Jul 19, 2012 | D. Cochrane Haywood | Executive | Purchase | 1,000 | $0.75 | $750 | |
| Jun 8, 2012 | Drutz David | Executive | Purchase | 25,000 | $0.77 | $19.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 20 | $221.1K | 35.0% |
Exercise(M) | 3 | $210.8K | 33.4% |
Conversion(C) | 1 | $200.0K | 31.7% |
Disposition(D) | 5 | $0 | 0.0% |
Award(A) | 15 | $0 | 0.0% |
Insiders at DARA BioSciences, Inc. are accumulating shares at an accelerated pace. With 9 insiders making 44 transactions totaling $221.1K in purchases versus $0 in sales, the net buying activity of $221.1K signals strong executive confidence. Richard A. Franco (Executive) leads the buying activity with $478.5K in transactions across all time.